Advertise in Biopharma Dealmakers Issues 2025
Promote your organization’s scientific products, technologies and research by advertising in Biopharma Dealmakers 2025 issues.
Connect with top industry scientists, biotech and pharma C-level executives, business development in big pharma, as well as the VC & investor community. Our sponsorship and advertising solutions position your brand within key circles, enhancing visibility, promoting breakthroughs, and driving thought leadership in cutting-edge science.
Book your spot:
1. Decide how you’d like to promote your brand with our 2025 issues — view the topics below.
2. Choose whether to run Branded Content, Digital Advertising, Webcasts and/or Email Marketing & e-Alerts Advertising:
a. Branded Content – Collaborate with us to create scientific content that showcases your expertise. Our marketing team will help boost your article’s reach with a targeted marketing package through social media channels, content and provide a detailed performance report. See examples here: Eli Lilly (Point Biopharma) and Janssen Oncology.
b. Digital Advertising – Increase your visibility by advertising in our print and digital editions of Nature Research journals, reaching key audiences at key partnering and investor events, focusing on topics such as partnering, therapeutic areas, technologies and regions of interest.
c. Webcasts – Host a webcast with us to attract targeted, qualified leads, establish your organization as an industry leader, and engage in meaningful discussions with your audience. You choose the topic and speakers; we manage promotion and logistics.
d. Email Marketing, and e-Alerts ads – connect with scientists through targeted emails based on subject area, journal, location, and more. Link to a contact form or gated content to generate leads. Advertise in Nature Research journal e-alerts, including Nature Biotechnology, Nature Reviews Drug Discovery, and Biopharma Dealmakers, to boost awareness, align with the Nature brand and enhance your brand’s impact!
2025 Biopharma Dealmakers Issues Calendar:
View the topics below and book with us before the booking deadlines.
| Publication month | Type of issue | Biopharma Dealmakers issues themes / tech | Conference distribution | Spotlight region | Booking deadline |
|---|---|---|---|---|---|
| February | Online collection | Metabolic diseases – including obesity and diabetes | BIO-Europe Spring (Milan, 17 – 19 March) American Association for Cancer Research (AACR) annual meeting (Chicago, USA, 25 – 30 April) Bio-Trinity (London, UK, 1 – 2 April) | 15 Nov 2024 | |
| March | Full issue | Oncology – solid tumours Drug delivery | BIO-Europe Spring (Milan, 17-19 March) American Association for Cancer Research (AACR) annual meeting (Chicago, USA, 25 – 30 April) Bio-Trinity (London, UK, 1 – 2 April) | Canada | 3 Dec 2024 |
| May | Online collection | Precision medicine – including genetic sequencing, gene editing and molecular diagnostics | Bio International Convention (Boston, 16 – 19 June) | 18 Jan 2025 | |
| June | Full issue | Infectious diseases – including AMR AI/ML/Big data, generative AI | Bio International Convention (Boston, 16 – 19 June) | East coast USA including Boston, New York and Philadelphia | 7 Mar 2025 |
| July | Online collection | RNA technoligies Nucleic-acid based drugs | BioPharm America (Boston, USA, 11 – 12 September) Bio-Europe (Vien na, 3 – 5 November) Society for Neuroscience annual meeting (San Diego, USA, 15 -19 October) | 16 Apr 2025 | |
| September | Full issue | Neurodegenerative disorders – including Alzheimer’s disease and dementia and/or Aging/longevity Antibody technologies, including ADCs | BioPharm America (Boston, USA, 11 -12 September) Bio-Europe (Vienna, 3 – 5 November) Society for Neuroscience annual meeting (San Diego, USA, 15 -19 October) | Europe | 9 Jun 2025 |
| October | Online collection | Protein technologies – including protein degradation | JP Morgan/Biotech Showcase (San Francisco, USA, 2026) | 22 Jul 2025 | |
| November | Online collection | Haematological disorders – including blood clotting and haemophilia | JP Morgan/Biotech Showcase (San Francisco, USA, 2026) | 22 Aug 2025 | |
| December | Full issue | Oncology – approaches used in treatments, including nanomedicines and radiopharmaceuticals Regenerative medicine (including CRISPR, cell & gene therapies, gene editing) | JP Morgan/Biotech Showcase (San Francisco, USA, 2026) | USA (San Francisco & Texas) | 5 Sep 2025 |
-
Direct Access to Industry Leaders
Reach a highly engaged audience of researchers, innovators, and decision-makers in biotech and pharmaceutical sectors who value our trusted content.
-
Targeted Engagement for You
Our advertising options are designed to ensure your message reaches the right professionals, helping you connect with your ideal audience effectively.
-
Custom Solutions Tailored to Your Needs
From digital ads to event sponsorships, we offer a range of customizable options to fit your marketing goal
-
Maximize Your Impact
Our sponsorship packages are crafted to amplify your message, build your credibility, and connect you with influential scientists, boosting your return on investment.
